Provention bio announces the grant of inducement award

Red bank, n.j., feb. 4, 2022 /prnewswire/ -- provention bio, inc. (nasdaq: prvb) (the "company"), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, today announced that the company granted stock options on february 1, 2022 to a new non-executive employee to purchase an aggregate of 30,000 shares of common stock.
PRVB Ratings Summary
PRVB Quant Ranking